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INTRODUCTION
Cesarean section (CS) is one of the most frequent surgical 
procedures worldwide carried out in an estimated propor-
tion of deliveries greater than 20% ranging to almost 40% 
in Italy (Souza et al., 2013; Gibbons et al., 2012; Mackeen et 
al., 2014). Surgical site infection (SSI), the most common 
healthcare-associated infection (HAI) among surgical pa-
tients, is an important complication of CS. A multicenter 
study conducted in the UK reported that 9.6% of women 
undergoing CS developed a SSI (Wloch et al., 2012). 
Therefore, SSI after CS may be a non-negligible burden on 
the Italian health system, Italy being among the European 
countries with the highest overall CS rate, accounting for 
38% of all deliveries (Euro Peristat, 2010).
Programs surveying SSI have been associated with a re-
duction in SSI incidence in a range of interventions (Mar-
chi et al., 2014; Rioux et al., 2007; Gastmeier et al., 2009). 
However, there is still no international agreement on the 
preferred method of surveillance. Due to the short length 
of post-operative hospital stay following most CS, SSI oc-
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curring mainly post-discharge could remain undetected 
by surveillance systems which fail to attain the usually 
recommended 30 day post-intervention follow-up with a 
consistent loss of observation (Moro et al., 2008; Marchi 
et al., 2010-2011; Grilli et al., 2012-2013; Ward et al., 2008; 
Koek et al., 2015).
We report the findings of three surveillances including 
post-discharge follow-up, conducted in the Latium Re-
gion, to determine the incidence of CS-associated SSI.
MATERIALS AND METHODS
In 2008 (April to June), 2011 (April to June), and 2013 
(March to May), as Regional Center for Healthcare Associ-
ated Infections, we coordinated three surveillances on SSI 
incidence after CS in community hospitals of the Latium 
Region, Central Italy. The surveillances were conducted in 
accordance with a protocol based on the Hospitals in Eu-
rope Link for Infection Control through Surveillance (HE-
LICS) project (ECDC, 2012a), and following the Centers 
for Diseases Control and Prevention/National Nosocomial 
Infections Surveillance (NNIS) methodology (Horan et al., 
2008; CDC, 2015).
Participation was voluntary, and 21 centers were enrolled 
in at least one of the three surveillances. The staff con-
ducting the survey in each participating center attended a 
training course before the start of each surveillance.
All consecutive CS, both performed in emergency or elec-
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tive surgery during the study period, were included. A set 
of demographic and clinical data, as well as the charac-
teristics of surgical procedures and data on peri-operative 
antibiotic use, was collected. Each CS was surveyed to 
assess the SSI occurrence up to 30 post-operative days. 
Diagnosis of SSI was defined, according to CDC/NNIS, as 
superficial incisional, deep incisional or organ/space SSI. 
Deep incisional and organ/space were further classified as 
complex SSI. Moreover, SSI were divided as during admis-
sion (i.e. during the hospital stay) or post-discharge SSI. 
During admission surveillance was performed by direct 
examination of patients’ wounds during daily visits or dai-
ly chart review before discharge after the surgical proce-
dure; post-discharge surveillance was performed by direct 
examination of patients’ wounds during the planned am-
bulatory surgical visits, chart review of ambulatory visit 
or, for consenting patients, through telephone interview 
conducted by trained staff using a standardized question-
naire. Data were collected using a modified version of the 
HELICS-Win software (Wilson et al., 2007) provided to 
each center.
Statistical analysis
The statistical analysis was performed using SPSS version 
22 (SPSS Inc., Chicago, IL, USA) and STATA version 13 
(Stata Corp LP, College Station, TX, USA).
χ2 test (or Fisher’s exact test when applicable) or Mann 
Whitney non-parametric test were used to compare groups 
for categorical or continuous variables respectively. The 
cumulative incidence (i.e. the crude percentage of surgical 
procedures resulting in a SSI) with its 95% confidence in-
tervals, (CI) was used to express the risk of SSI.
Association of SSI with relevant characteristics was as-
sessed using binomial logistic regression and expressed 
with relative risk (RR) and their respective 95% CI. Vari-
ables included in the analysis were year of surveillance, 
age, National Nosocomial Infections Surveillance (NNIS) 
risk-index score (CDC, 2015), pre-surgery stay, type of in-
tervention, and peri-operative antibiotic use.
RESULTS
A total of 3,685 CS were included in the study (1,185 in 
2008, 535 in 2011 and 1,965 in 2013) (Table 1).
Overall post-operative follow-up added up to a total of 
105,794 person-days, of which in-hospital stay account-
ed for 15,399, with a median of 3.5 days (IQR: 3.5-4.5). 
A complete 30 day follow-up was achieved in over 94% 
of procedures, with a mean length of observation of 28.7 
days.
Peri-operative antibiotic administration was performed 
in 3,462 surgical operations (93.9%). Of 2,292 procedures 
performed in 2011 and 2013, 53.1% of antibiotics were ad-
ministered at umbilical cord clamping, while 35% within 
1 hour before skin incision (data not available for 2008 
surveillance study).
Table 1 - Characteristics of 3,685 caesarean sections surveyed.
N. %
Total 3,685
Median Patient Age (IQR) 34 (30-37)
year of surveillance 2008 1,185 32.2
2011 535 14.5
2013 1,965 53.3
Type of intervention Election 1,903 51.7
Emergency 1,772 48.1
NA 10 0.3
Wound class Clean/clean contaminated 3.557 96.6
Contaminated/Dirty 99 2.7
NA 29 0.8
ASA score 1-2 3,062 83.1
3-5 155 4.1
NA 468 12.7
Duration of the procedure >75th percentile No 3,183 86.4
yes 498 13.5
NA 4 0.1
NNIS risk-index score 0 2,564 70.0
1 606 16.5
2 28 0.8
NA 468 12.7
Pre-surgery stay (days) 0-1 3,113 84.3
2+ 572 15.5
ASA: American Society Anesthesiologists; NA: Not available; NNIS: National Nosocomial Infections Surveillance; IQR: Interquartile Range.
F. Ferraro, P. Piselli, S. Pittalis, L.E. Ruscitti, C. Cimaglia, G. Ippolito, V. Puro, et al.136
A total of 145 SSI were observed, with a cumulative inci-
dence of 3.9% (95% CI: 3.3-4.6); 131 (90.3%) were superfi-
cial incisional, while 14 were complex (6 deep and 8 organ/
space) (Table 2). Overall, diagnosis of SSI was ascertained 
at a median time of 9.5 days after CS (IQR: 6.5-11.5).
A trend of increasing SSI risk was observed through sur-
veillance periods with a cumulative incidence ranging 
from 2.4% in 2008, to 4.1% in 2011 and 4.8% in 2013. 
However, when considering the complex SSI, the cumu-
lative incidence decreased over time from 0.8% in 2008 
to 0.2% in 2011 and 2013, while the cumulative incidence 
for superficial SSI increased from 1.6% in 2008 up to 3.9% 
and 4.6% in 2011 and 2013 respectively.
Sixteen SSI (11.0%) were detected during admission 
(0.4% cumulative incidence): all but one were superficial 
SSI, while only one was an organ/space SSI. Of the 129 
post-discharge SSI, 116 (89.9%) were superficial, and 13 
complex (6 deep and 7 organ/space) (Table 2). 
No difference in post-operative hospital length of stay was 
reported for patients who developed SSI during admission 
vs post-discharge (p=0.664).
In the binomial logistic regression analysis the only vari-
able resulting significantly (p<0.05) associated with SSI 
occurrence was increasing NNIS score 1-2 (vs 0 score, 
RR=2.06, 95% CI: 1.43-2.96). Peri-operative antibiotic use 
was associated, al Puro though not significantly, with a di-
minished SSI risk (Table 3). Timing of antibiotic use, at 
clamping or at skin incision, was not associated with SSI 
risk (data not shown).
DISCUSSION
Even if limited by voluntary participation and performed 
in relatively brief periods, our work provides the first re-
gional data on CS-associated SSI incidence, monitoring 
approximately 10% of overall CS procedures performed in 
the study period in the Latium Region (ASP-Lazio, 2011). 
This is a first step in the challenge of harmonization of 
regional SSI surveillance and control activities, through 
the data reporting for aggregation into a single regional 
database, according to a common protocol.
Our data show a SSI incidence higher than those from the 
national surveillance, collected in the same years (2.45% 
vs 1.90% in 2008, 4.11% vs 2.58% in 2011 and 4.78% vs 
1.75% in 2013) (Moro et al., 2008; Marchi et al., 2010-2011; 
Grilli et al., 2012-2013). Similar findings can be observed 
when comparing our results with the European surveil-
lance performed in 2008 and 2011 (3.58% and 2.98%, re-
Table 2 - Distribution of surgical site infection cases among 3,685 caesarean sections surveyed. 
Year N. SSI (%) In-Hospital/Post-discharge*
Superficial/Complex#
2008 1,185 29 (2.4) 1/28 19/10
2011 535 22 (4.1) 1/21 21/1
2013 1,965 94 (4.8) 14/80 91/3
Total 3,685 145 (3.9) 16/129 131/14
*SSI occurred during original hospital admission (In-Hospital) or post-discharge. #Complex SSI include deep and organ-space infections.
Table 3 - Analysis of risk factors associated with SSI after caesarean section. 
Tot
(N=3,685)
SSI
(N=145) RR* (95% CI)
year of surveillance 2008 1,185 29 0.66 (0.38-1.16)
2011 535 22 Ref.
2013 1,965 94 1.28 (0.79-2.06)
Age (yrs) By 5 years increase 1.06 (0.93-1.22)
NNIS risk-index score 0 2,564 86 Ref.
1-2 634 43 2.06 (1.43-2.97)
NA 487 16 0.96 (0.56-1.63)
Pre-surgery stay (days) 0-1 3,113 116 Ref.
2+ 572 29 1.33 (0.90-1.99)
Type of intervention Election 1,903 74 Ref.
Emergency 1,772 70 1.01 (0.73-1.39)
NA 10 1 2.18 (0.35-13.57)
Antibiotic use No 199 12 Ref.
yes 3,462 132 0.75 (0.42-1.33)
NA 24 1 0.77 (0.10-5.83)
RR: Relative Risk; CI: Confidence Intervals; NNIS: National Nosocomial Infections Surveillance; NA: Not available. *Model adjusted for all variables 
included in the table.
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spectively) (ECDC 2012b; ECDC 2013). Nevertheless when 
considering only SSI diagnosed during admission, our re-
gional incidence was lower than national estimates in the 
first two surveillances (0.08% vs 0.34% in 2008 and 0.19% 
vs 0.28% in 2011) while higher in 2013 study (0.71% vs 
0.34%) (Moro et al., 2008; Marchi et al., 2010-2011; Grilli et 
al., 2012-2013). Conversely, post-discharge SSI cumulative 
incidence was constantly higher than national estimates, 
almost tripling in the last surveillance (2.36% vs 1.54% 
in 2008; 3.93% vs 2.28% in 2011 and 4.07% vs 1.33% in 
2013).
The national surveillance, as well as other similar stud-
ies, reports average and median length of surveillance 
extremely variable from 20 to 14 days, making it hard to 
have a clear and meaningful intercomparison (Moro et 
al., 2008; Marchi et al., 2010-2011; Grilli et al., 2012-2013; 
Ward et al., 2008). Although SSI incidence is reported at 
comparable rates, the observed differences may be partial-
ly still affected by the different follow-up performed, SSI 
incidence not being a linear function of time after inter-
vention (Koek et al., 2015). To allow comparison, a fixed 
duration of follow-up should thus be appropriate.
In our study, two results are noteworthy: the increasing 
trend of SSI cumulative incidence, and the proportion of 
post-discharge complex SSI. The inability to evaluate the 
presence of comorbidities, not considered in the shared 
protocol, associated with a higher risk of SSI precludes 
a proper risk factor assessment, but confirms the known 
association of increased NNIS score with SSI risk (Fried-
man et al., 2007).
The increasing trend of SSI cumulative incidence has to 
be ascribed to superficial SSI, that accounted for almost 
all (96%) SSI observed in the last two surveillances, while, 
when considering only complex SSI, the incidence actu-
ally dropped from 0.84% in 2008 to 0.19% in 2011 and 
0.15% in 2013. Although we cannot exclude in our Region 
a real worsening in the occurrence of superficial infections 
following CS, we believe that these findings are more like-
ly due a better post-discharge detection capacity acquired 
through experience (11/21 centers participated at least 
two regional surveillances). Indeed, the post-discharge 
SSI were primarily superficial. Recently, it has even been 
proposed to exclude superficial SSI and/or SSI diagnosed 
out of healthcare setting from the surveillance, as the sub-
jective, inconsistent and prone to error diagnosis of them, 
especially if patient self-assessed, leading to a wide vari-
ability of data reporting, and to their unreliability as a 
proxy of health system quality (Kao et al., 2011; Ming et 
al., 2012).
In our experience, the recommended 30 day post-discharge 
surveillance was also labour intensive (Koek et al., 2015). 
However, since we were able to perform a recommended 
30-day surveillance in the majority of cases, we were able 
to detect almost all complex SSI (13/14) in post-discharge.
Due to the usually short hospitalization after caesarean 
delivery, shorter follow-up limited to the hospital admis-
sion would have missed these infections.
Complex SSI are likely to require medical care in the 
healthcare setting, in which adherence to standardized 
surveillance methods is more easily attained. Thus, sur-
veillance of complex SSI is more likely to be unaffected 
by underreporting if a complete 30 day follow-up is raised 
(Koek et al., 2015) even when a “passive” approach is ap-
plied. Løwer et al. reported that at least after hip arthro-
plasty, an active surveillance within 30 days followed by a 
passive surveillance relying on data on hospital readmis-
sion up to 90 days post-intervention can replace full-active 
90 days surveillance without reducing sensitivity (Løwer 
et al., 2015).
We therefore highlight the need for approaches alternative 
to traditional surveillance methods which should assure 
30 days post-operation discharge so as not to miss data on 
complex SSI, as well as being less labour intensive. More-
over, these approaches should keep data comparable.
Clinical data on complex SSI and antibiotic use should 
be readily available in electronic records implemented in 
healthcare systems (Ming et al., 2012). Linking in an auto-
mated electronic surveillance system hospital admission 
ICD (International Classification of Diseases) codes with 
antibiotic administration (in-hospital and in out-patient 
settings) in the 30 days period after surgical procedures 
could be a useful proxy of SSI occurrence, warranting fur-
ther evaluation.
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